After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Plus Therapeutics Inc (PSTV) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.005, or -0.31%, to $1.60. The Plus Therapeutics Inc has recorded 125,393 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to Rhenium (186Re) Obisbemeda for the Treatment of Breast Cancer with Leptomeningeal Metastases.
PSTV belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $1.61 and fluctuated between $1.6300 as its day high and $1.4400 as its day low. The current market capitalization of Plus Therapeutics Inc is $7.25M. A total of 0.51 million shares were traded on the day, compared to an average of 639.01K shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, PSTV has seen 2 BUY and 0 SELL insider trades, representing the acquisition of 26,993 and the disposition of 0 shares. Over the last 12 months, there were 5 BUYs and 1 SELLs from insiders. Insiders purchased 30,494 shares during that period but sold 1,500.
In the most recent transaction, Clowes Howard bought 6,993 shares of PSTV for 1.43 per share on Sep 13. After the transaction, the Director now owns 11,693 company shares. In a previous transaction on Sep 11, Petersen Greg bought 20,000 shares at 1.70 per share. PSTV shares that Director owns now total 24,166.
Among the insiders who bought shares, Clowes Howard acquired of 1,000 shares on Jun 06 at a per-share price of $3.98. This resulted in the Director holding 4,700 shares of PSTV after the transaction. In another insider transaction, Clowes Howard bought 2,500 shares at $3.64 per share on May 03. Company shares held by the Director now total 3,700.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for PSTV in the last 3 months, the mean price target is $17.50 with high estimates of $32.00 and low estimates of $4.00. In terms of 52-week highs and lows, PSTV has a high of $7.50 and a low of $0.97.
As of this writing, PSTV has an earnings estimate of -$1.12 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.58 per share and a lower estimate of -$1.86. The company reported an EPS of -$2.1 in the last quarter, which was -10.50% lower than expectations of -$1.9.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. PSTV’s latest balance sheet shows that the firm has $18.40M in Cash & Short Term Investments as of fiscal 2021. There were $6.99M in debt and $5.87M in liabilities at the time. Its Book Value Per Share was $0.58, while its Total Shareholder’s Equity was $10.84M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PSTV is Buy with a score of 5.00.